Title: Adhesion Barrier Market
1Adhesion Barrier Market
Due to the increasing geriatric population and
the growth of a number of surgeries, the Global
Adhesion barrier market is growing at a
significant pace. Due to its advantages, such as
bioabsorbable properties and cost-effectiveness,
a large number of commercially available
synthetic adhesion barriers and higher use of the
adhesion barrier by surgeons in many surgeries,
the industry has seen strong demand for synthetic
adhesion barriers in the coming years. By
product, the adhesion barrier market is
subdivided into natural adhesion barriers and
synthetic adhesion barriers. Synthetic adhesion
barriers segment accounted the largest share and
is expected to grow at the fastest rate in the
adhesion barrier market. By formulation, the
market is subdivided into film formulations, gel
formulations, and liquid formulations. The film
formulation accounted foremost share in the
adhesion barrier market. By application, the
market is subdivided into gynaecological
surgeries, neurological surgeries,
reconstructive surgeries, cardiovascular
surgeries, urological surgeries,
general/abdominal surgeries, orthopedic
surgeries, and other surgeries. The
gynaecological surgeries application accounted
the largest share in the adhesion barrier
market. The key growth factors for the adhesion
barrier market are the expansion of the geriatric
population, growing alertness regarding the
medical inference of post-surgical adhesion
formulation, and an increase in the number of
surgeries and sports-related injuries. The growth
of the adhesion barrier market is also
facilitated by the growing prevalence of chronic
diseases due to the geriatric population, the
escalation and epidemiological change from
infectious to chronic diseases. The adhesion
barriers are used in several surgical procedures
to separate internal tissue and organ during the
healing process. Disinclination regarding the
usage of adhesion barriers amongst surgeons and
strict regulations resultant in inadequate
technological innovations are the major
challenges for the growth of the adhesion
barrier market. Recent News In October 2018,
FzioMed, Inc. launched Oxiplex/IU in the European
Union for intrauterine surgery to improve
surgical outcomes by decreasing post-surgical
adhesions. Competitive Insights Johnson
Johnson, C. R. Bard, Inc., FzioMed, Inc., Sanofi,
Anika Therapeutics, Baxter International, Inc.,
MAST Biosurgery, Integra LifeSciences Holdings
Corporation, Getinge Group, and Betatech Medical
are the key players offering adhesion barrier.
2VynZ Research Call 91-996-028-8381 Toll-Free
(U.S. and Canada) 1-888-253-3960 Email
enquiry_at_vynzresearch.com Web https//www.vynzrese
arch.com Connect with Us LinkedIn Facebook
Twitter